NCPA Representative Discusses Role in Influencing PBM Reform
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.
At the National Community Pharmacists Association (NCPA), Steve Postal, JD, Director of Policy and Regulatory Affairs, helps independent pharmacies advocate for change in the pharmacy benefits space. While it’s no secret that pharmacy benefit managers (PBMs) hold an immense amount of power in influencing drug pricing, many legislative vehicles have been put into motion to give some of that power back to smaller pharmacies.
“Pharmacy benefit managers (PBMs) play a major role in the provision of pharmacy services by acting as the intermediary between pharmacies, plan sponsors (insurance companies and employers), pharmaceutical manufacturers, and drug wholesalers. Over the decades, PBMs have expanded their influence in the pharmaceutical supply chain and now handle claims processing, formularies, pharmacy networks, mail-order pharmacies, and contracting with wholesalers and manufacturers. As their role and visibility have increased, PBMs have come under increased scrutiny from policymakers,” wrote authors of a study published in JAMA Health Forum.1
Postal discussed major changes in the PBM space regarding federal and state legislation. | image credit: tracy / stock.adobe.com
In our chat with Postal, he discussed major changes in the PBM space regarding state legislation. While federal legislation that takes power away from PBMs is the ultimate goal, movement on the state level has been much more possible for local pharmacists and their state pharmacy associations.
“I think, on the state level, state advocacy can be much closer to the ground and there tends to be more grassroots involvement, which is a good thing. Pharmacy too is often typically more of a state-regulated issue,” Postal told Drug Topics.
Listen to the full-length version of our discussion with Postal on Spotify and discover some incredible insights into what needs to be done to curb the growth and power PBMs have overtaken in recent decades.
READ MORE: Q&A: What the NCPA is Doing to Fight Back Against PBMs
Pharmacy practice is always changing. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
Reference
1. Mattingly TJ, Hyman DA, Bai G. Pharmacy benefit managers: history, business practices, economics, and policy. JAMA Health Forum. 2023;4(11):e233804. doi:10.1001/jamahealthforum.2023.3804
ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs
February 17th 2025The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.
